China's National Medical Products Administration accepted Huadong Medicine's (SHE:000963) application for the registration of its Primelase Semiconductor Laser Therapy System, according to a Shenzhen bourse filing on Tuesday.
Primelase, which is developed by subsidiary High Technology Products, is a semiconductor laser multi-parameter adjustable therapeutic device,
The drugmaker's shares slipped 1% at the close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments